[ACRX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 68.95%
YoY- 79.90%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 117 507 1,862 1,368 608 377 1,487 -34.52%
PBT -1,416 -6,739 -8,375 -8,930 -12,731 -12,458 -13,013 -30.89%
Tax 2 11 796 931 1,212 -2,601 -3,233 -
NP -1,357 -6,750 -8,375 -8,930 -12,731 -12,458 -13,013 -31.38%
Tax Rate - - - - - - - -
Total Cost 1,474 7,257 10,237 10,298 13,339 12,835 14,500 -31.67%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -1,159.83 -1,331.36 -449.79 -652.78 -2,093.91 -3,304.51 -875.12 4.80%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.08 -0.91 -1.40 -2.03 -3.20 -4.15 -5.61 -50.73%
EPS Diluted -0.08 -0.91 -1.40 -2.03 -3.20 -4.15 -5.61 -50.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.